-
公开(公告)号:US20170340591A1
公开(公告)日:2017-11-30
申请号:US15538031
申请日:2015-12-23
申请人: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET LA RECHERCHE MÉDICALE , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , UNIVERSITE DE NICE SOPHIA ANTIPOLIS-GRAND CHÂTEAU
CPC分类号: A61K31/197 , A61K31/00 , A61K35/39 , A61K39/00 , A61K45/06 , A61K2039/505 , C07K16/26 , C07K2317/76 , C12N5/0676 , C12N2501/335 , C12N2501/845 , C12N2506/22 , A61K2300/00
摘要: The present invention relates to methods of generating a population of beta cells from a population of alpha cells, by contacting said population of alpha cells with GABA or a GABA receptor agonist, in combination with a monoclonal glucagon neutralizing antibody or other alpha cell mass regulating compounds, for an improved diabetes therapy.